SCA Pharmaceuticals is a recognized leader in the field of sterile compounding, thanks to our leadership team with three decades of experience. SCA specializes in preparing sterile pharmaceuticals customized for hospitals pharmacies and healthcare facilities nationwide. Our products and services have consistently proven to significantly increase efficiencies and reduce costs to these organizations. Our dedicated and talented team members are passionate about providing the highest quality products and service to our valued customers.
SCA Pharmaceuticals is committed to quality by design, compliance with FDA guidelines, upholding the highest ethical standards in the industry, and ensuring the best clinical care and patient safety. SCA Pharmaceuticals has invested in the latest technological advancements in sterile pharmaceutical production and quality control with Rapid Microbiological capabilities.
Mr. Boyer has served in technical, commercial and executive roles in the pharmaceutical industry for more than 25 years with a specific focus in contract manufacturing
for both drug substance and sterile drug product. For the last decade, he has been involved in sterile drug product manufacturing, most recently as the Senior Vice President of Drug Product Manufacturing at AMRI, a global contract research and manufacturing organization. Mr. Boyer joined AMRI in 2014 upon AMRI’s acquisition of Oso BioPharmaceuticals, where he served as President and CEO and as a member of the Board of Directors.
Active in trade groups and educational institutions that support the pharmaceutical and biopharmaceutical industry, Mr. Boyer serves on the board of directors of the Drug, Chemical & Allied Trades Association (DCAT) and is now on the executive committee as its President. He has also served on the external advisory board for the University of New Mexico’s chemistry and biology department and been an active member of other professional organizations, including the American Association of Pharmaceutical Scientists, the Parenteral Drug Association and the Society of Chemical Manufacturers and Affiliates
Mr. Boyer has a bachelor’s in chemistry/physics and a master’s in biochemistry from Hardin-Simmons University and Texas Tech University.
Grace Breen brings over 30 years of experience in the pharmaceutical industry to SCA, previously holding global leadership positions at Impax, Hospira and Catalent Pharma Solutions. She has extensive quality and compliance expertise that spans API’s, solid dosage forms, parenterals, and infusion devices. While at Impax, Grace spearheaded the development and execution of a contemporary quality and compliance strategy and during her tenure at Hospira, Grace lead a global commercial quality group that focused on the needs and satisfaction of the customer.
Grace holds a post-graduate diploma in pharmaceutical manufacturing technology from Trinity College Dublin, Ireland, an M.S. in chemistry from Dublin City University, Ireland and a B.S. in chemistry from University College Cork, Ireland.
Matt White received his Doctor of Pharmacy degree from the University of Arkansas College of Pharmacy where he earned admission to Rho Chi for his high academic achievements. Matt has advanced training and certification in "High Risk Sterile Compounding" from the University of Tennessee College of Pharmacy. He has multiple years of sterile compounding experience and previously worked in one of the largest Acute Care Hospital facilities in the South.
Chris Musser holds a Bachelor’s in Pharmacy, and a Master’s in Project Management to go along with his MBA.
Chris brings over 25 years of pharmaceutical experience to SCA with over 15 years specifically dedicated to pharmaceutical manufacturing.
A certified Lean Six Sigma Black Belt, Chris has successfully led large groups and organizations for over a decade for multi-billion-dollar pharmaceutical companies. He has also implemented several transformational change management initiatives, reorganizing, and reshaping organizations, people, processes, and systems.
Cindy Mitman received her Bachelor’s in Chemistry from Methodist University, her PharmD from Temple University and her MBA from DeSales University.
Cindy brings more than 15 years of pharmaceutical experience including over 14 years in hospital pharmacy to her role as Director of Production for SCA Pharmaceuticals Northeast facility. She previously held the position of Assistant Director of Pharmacy at Lehigh Valley Health Network with direct oversight of sterile compounding and outsourcing.
Cindy also holds an Aseptic Processing Certification from Baxter Health Care, and Current Good Manufacturing Practices certification from USP, Rockville, MD
Michelle Wood is responsible for growing SCA across the country. Michelle consults with Directors of Pharmacy, Anesthesiologists, Surgeons, Clinical Coordinators, Purchasing/Materials Management, and other key contacts for outsourcing over 250 drugs ranging from Class II through Class IV drugs. Michelle spent many years developing relationships with many different Corporate GPOs, IDNs, and other C-Level key contacts nationwide, and has implemented a number of large corporate purchasing contracts. She has helped launch many new products for SCA Pharmaceuticals and continues to lead SCA’s marketing team into the future.
Lisa McKenzie holds a Bachelor’s in Management with an MBA in Business Administration and is a Doctoral Candidate in Healthcare Management with an expected completion date of 2020.
She brings over 15 years’ experience to her role with industry expertise in project management, highly effective training modules inclusive of all levels of an organization, and customer relationship management systems implementation.
In her role, Lisa focuses on developing training and education strategies to continuously improve effectiveness, and standardize and harmonize operational processes for SCA Pharmaceuticals.